Literature DB >> 1417831

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

B I Terman1, M Dougher-Vermazen, M E Carrion, D Dimitrov, D C Armellino, D Gospodarowicz, P Böhlen.   

Abstract

Vascular endothelial cell growth factor (VEGF), also known as vascular permeability factor, is an endothelial cell mitogen which stimulates angiogenesis. Here we report that a previously identified receptor tyrosine kinase gene, KDR, encodes a receptor for VEGF. Expression of KDR in CMT-3 (cells which do not contain receptors for VEGF) allows for saturable 125I-VEGF binding with high affinity (KD = 75 pM). Affinity cross-linking of 125I-VEGF to KDR-transfected CMT-3 cells results in specific labeling of two proteins of M(r) = 195 and 235 kDa. The KDR receptor tyrosine kinase shares structural similarities with a recently reported receptor for VEGF, flt, in a manner reminiscent of the similarities between the alpha and beta forms of the PDGF receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417831     DOI: 10.1016/0006-291x(92)90483-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  262 in total

1.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.

Authors:  T E Godfrey; S H Kim; M Chavira; D W Ruff; R S Warren; J W Gray; R H Jensen
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor.

Authors:  Rizwan Masood; Ethel Cesarman; D Lynne Smith; Parkash S Gill; Ornella Flore
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

3.  Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity.

Authors:  I Lang; C Hoffmann; H Olip; M A Pabst; T Hahn; G Dohr; G Desoye
Journal:  Cell Prolif       Date:  2001-06       Impact factor: 6.831

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 5.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

6.  Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma.

Authors:  Lin Zhang; Nuo Yang; Jose-Ramon Conejo Garcia; Alisha Mohamed; Fabian Benencia; Stephen C Rubin; David Allman; George Coukos
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

7.  Inhibitory effect of antisense vascular endothelial growth factor 165 eukaryotic expression vector on proliferation of hepatocellular carcinoma cells.

Authors:  Song Gu; Chang-Jian Liu; Tong Qiao; Xue-Mei Sun; Lei-Lei Chen; Le Zhang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

Review 8.  Emerging techniques to treat corneal neovascularisation.

Authors:  J Menzel-Severing
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

Review 9.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 10.  Regulation of microvascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; N J Hillman; B Williams; C R Neal; T M Pocock
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.